[New European approvals: Alpelisib for HRpos/HER2neg metastatic breast cancer with PIK3CA mutation].

[New European approvals: Alpelisib for HRpos/HER2neg metastatic breast cancer with PIK3CA mutation]. Bull Cancer. 2020 Sep 22;: Authors: Corbaux P, Sabatier R PMID: 32977934 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32977934?dopt=Abstract

Source: Bulletin du Cancer - September 21, 2020 Category: Cancer & Oncology Authors: Corbaux P, Sabatier R Tags: Bull Cancer Source Type: research

More News: Breast Cancer | Cancer | Cancer & Oncology | Science